Work

A phase-II study of low-dose cyclophosphamide and recombinant human interleukin-2 in metastatic renal cell carcinoma and malignant melanoma

Year: 1989

Type: article

Study design: Clinical Trial

Source: Cancer Immunology Immunotherapy

DOI: 10.1007/bf00205237

Authors: Albrecht Lindemann, Klaus H�ffken, ReinholdE. Schmidt, Volker Diehl, Otto Kloke, Heinold Gamm, J�rg Hayungs, Wolfgang Oster, Markus B�hm, JonathanE. Kolitz, ChrisR. Franks, Friedhelm Herrmann, RolandH. Mertelsmann

Institutions: Johannes Gutenberg University Mainz, University of Duisburg-Essen, Leibniz University Hannover, University of Cologne, Memorial Sloan Kettering Cancer Center

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W2094295055

FWCI: 2.767

Cites: 36

Cited by: 45

Related to: 10